EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 5-Jul-2025 11:10 ET (5-Jul-2025 15:10 GMT/UTC)

Study introduces online tool to guide surgical decisions for gallbladder cancer

Boston University School of Medicine
Peer-Reviewed Publication

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine have discovered key risk factors that can help predict when surgery for gallbladder cancer may not be beneficial, leading to ER or complications.

Journal: Annals of Surgical Oncology

Stand up to cancer adds new expertise to scientific advisory committee

Stand Up To Cancer
Business Announcement

Stand Up To Cancer has added new expertise to our Scientific Advisory Committee, which oversees SU2C’s scientific research in collaboration with our President and CEO, Julian Adams, Ph.D. With expertise in the areas of pediatric oncology, biostatistics and healthcare economics, our three newest members will be critical partners as we invest in bold science with the goal of reducing cancer deaths.

Prevalence of neutralizing antibodies to AAV2 and AAV9 in individuals with Niemann-Pick disease

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against either adeno-associated virus (AAV) 2 or AAV9.

Journal: Human Gene Therapy

Reprogramming immune cells to improve cancer treatment

Vlaams Instituut voor Biotechnologie
Peer-Reviewed Publication

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer, showing promise for improving patient outcomes in difficult-to-treat malignancies. Their work appears in Nature Metabolism.

Journal: Nature Metabolism
Funder: FWO, Stichting Tegen Kanker, NIH, ERC

Shimadzu Corporation and DxD Hub establish joint lab to advance diagnostics innovation and improve healthcare outcomes

Agency for Science, Technology and Research (A*STAR), Singapore
Business Announcement

Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hub), a national platform hosted by Singapore’s Agency for Science, Technology and Research (A*STAR), are pleased to announce a strategic collaboration to establish the Shimadzu – DxD Hub Diagnomics Centre (SDDC) at Biopolis, Singapore. Officially launched today, the SDDC will drive innovation and accelerate the development of diagnostic products by integrating Shimadzu’s technological expertise with DxD Hub’s productisation platforms.

Do firefighters face a higher brain cancer risk associated with gene mutations caused by chemical exposure?

Wiley
Peer-Reviewed Publication

Gene mutations caused by exposure to certain chemical compounds have been linked to the development of gliomas, the most common type of malignant brain tumor. New research published by Wiley online in CANCER reveals that among patients with gliomas, these mutations are more common in firefighters than in individuals with other occupations.

Journal: Cancer

New immune mechanism revealed in the cellular trash

Weizmann Institute of Science
Peer-Reviewed Publication

Research on how proteasomes generate antimicrobial peptides, revealing a new immune mechanism with potential applications for combating antibiotic resistance

Journal: Nature

Walking, moving more may lower risk of cardiovascular death for women with cancer history

American Heart Association
Reports and Proceedings

Increased physical activity including taking more daily steps was linked to a lower risk of death from cardiovascular disease among postmenopausal women with a history of cancer.

Meeting: AHA Scientific Sessions 2024

VUMC to develop AI technology for therapeutic antibody discovery

Vanderbilt University Medical Center
Grant and Award Announcement

VUMC has been awarded up to $30 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a massive antibody-antigen atlas, develop AI-based algorithms to engineer antigen-specific antibodies, and apply the AI technology to identify and develop potential therapeutic antibodies.

Funder: Advanced Research Projects Agency for Health

Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine

Compuscript Ltd
Peer-Reviewed Publication

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases. The study highlights the transformative potential of EZH2 inhibition, paving the way for a new generation of targeted therapies aimed at disrupting tumor growth and overcoming treatment resistance.

Journal: Genes & Diseases
Funder: Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine (China), National Natural Science Foundation of China, Foundation for Basic and Applied Research of Guangdong Province, China, Foundation for Basic and Applied Research of Guangdong Province, China, Chinese Medicine Science and Technology Research Project of Guangdong Provincial Hospital of Chinese Medicine (China), Guangzhou Science and Technology Plan Project (Guangdong, China), Guangzhou Science and Technology Plan Project (Guangdong, China), Key Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine Jointly Built by Province and Ministry (China), Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases (China), Guangdong Traditional Chinese Medicine Project (China), Guangdong Traditional Chinese Medicine Project (China)